• Scinai Immunotherapeutics closed a private placement and warrant inducement on Oct. 16, 2026, raising approximately $4 million before fees and expenses.
• The placement comprised 2,458,334 ADSs (or pre-funded warrants) with Series A-1 Warrants to purchase up to 3,687,501 ADSs.
• Existing Warrants covering up to 879,194 ADSs were exercised at a reduced price of $1.20 per ADS.
• The warrant inducement included additional Series A-1 Warrants to purchase up to 1,318,791 ADSs.
• Net proceeds will support customer programs, additional contract development and manufacturing business, and selective immunotherapy pipeline investment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scinai Immunotherapeutics Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: LN74161) on October 16, 2026, and is solely responsible for the information contained therein.